ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 17.25
+0.60 (3.60%)
Aug 14, 2025, 1:35 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 13.64 billion as of August 14, 2025. Its market cap has decreased by -36.35% in one year.
Market Cap
13.64B
Enterprise Value
11.27B
Revenue
3.19B
Ranking
n/a
PE Ratio
69.14
Stock Price
17.25
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 13.64B, a decrease of -55.18%. That is a compound annual growth rate of -5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 13.64B | -21.77% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | 22.81B | 8.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 208.61B |
| PharmaEssentia | 167.97B |
| Bora Pharmaceuticals Co., LTD. | 94.94B |
| Lotus Pharmaceutical | 53.66B |
| Oneness Biotech | 32.28B |
| Polaris Group | 27.70B |
| Center Laboratories | 26.60B |
| Lumosa Therapeutics | 25.91B |